Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.

Breyer MK, Rutten EP, Locantore NW, Watkins ML, Miller BE, Wouters EF; ECLIPSE Investigators (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints)..

Eur J Clin Invest. 2012 Sep;42(9):983-91. doi: 10.1111/j.1365-2362.2012.02686.x. Epub 2012 Jun 15.

PMID:
22703238
2.

Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease.

van den Borst B, Gosker HR, Wesseling G, de Jager W, Hellwig VA, Snepvangers FJ, Schols AM.

Am J Clin Nutr. 2011 Dec;94(6):1504-12. doi: 10.3945/ajcn.111.023911. Epub 2011 Nov 9.

3.

Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.

Breyer MK, Rutten EP, Vernooy JH, Spruit MA, Dentener MA, van der Kallen C, vanGreevenbroek MM, Wouters EF.

Respir Med. 2011 Jul;105(7):1046-53. doi: 10.1016/j.rmed.2011.02.001. Epub 2011 Mar 1.

4.

Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.

Kirdar S, Serter M, Ceylan E, Sener AG, Kavak T, Karadağ F.

Scand J Clin Lab Invest. 2009;69(2):219-24. doi: 10.1080/00365510802474400.

PMID:
18946779
5.

Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.

Krommidas G, Kostikas K, Papatheodorou G, Koutsokera A, Gourgoulianis KI, Roussos C, Koulouris NG, Loukides S.

Respir Med. 2010 Jan;104(1):40-6. doi: 10.1016/j.rmed.2009.08.012. Epub 2009 Sep 25.

6.

Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.

Clin Sci (Lond). 2008 Oct;115(7):225-32. doi: 10.1042/CS20070382.

PMID:
18307413
7.

Local inflammation occurs before systemic inflammation in patients with COPD.

He Z, Chen Y, Chen P, Wu G, Cai S.

Respirology. 2010 Apr;15(3):478-84. doi: 10.1111/j.1440-1843.2010.01709.x. Epub 2010 Feb 24.

PMID:
20210891
8.

IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.

Yanbaeva DG, Dentener MA, Spruit MA, Houwing-Duistermaat JJ, Kotz D, Passos VL, Wouters EF.

BMC Med Genet. 2009 Mar 9;10:23. doi: 10.1186/1471-2350-10-23.

9.

Associations between BODE index and systemic inflammatory biomarkers in COPD.

Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S.

COPD. 2011 Dec;8(6):408-13. doi: 10.3109/15412555.2011.619599.

PMID:
22149400
10.

Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis.

Yoshino T, Kusunoki N, Tanaka N, Kaneko K, Kusunoki Y, Endo H, Hasunuma T, Kawai S.

Intern Med. 2011;50(4):269-75. Epub 2011 Feb 15.

11.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Epub 2010 Nov 26. Spanish.

12.

The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients.

Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB.

Int J Artif Organs. 2004 Oct;27(10):835-41.

PMID:
15560677
13.

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.

Karadag F, Kirdar S, Karul AB, Ceylan E.

Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.

PMID:
18249305
14.

Circulating visfatin in chronic obstructive pulmonary disease.

Liu X, Ji Y, Chen J, Li S, Luo F.

Nutrition. 2009 Apr;25(4):373-8. doi: 10.1016/j.nut.2008.09.008. Epub 2008 Dec 4.

PMID:
19056239
15.

Relation between physical capacity, nutritional status and systemic inflammation in COPD.

Hallin R, Janson C, Arnardottir RH, Olsson R, Emtner M, Branth S, Boman G, Slinde F.

Clin Respir J. 2011 Jul;5(3):136-42. doi: 10.1111/j.1752-699X.2010.00208.x. Epub 2010 Jun 7.

PMID:
21679348
16.

Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism.

Broekhuizen R, Grimble RF, Howell WM, Shale DJ, Creutzberg EC, Wouters EF, Schols AM.

Am J Clin Nutr. 2005 Nov;82(5):1059-64.

17.

Genetic and biochemical markers of obstructive lung disease in the general population.

Dahl M.

Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.

PMID:
20298391
18.

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J; EPI-SCAN Steering Committee..

Respir Res. 2010 May 25;11:63. doi: 10.1186/1465-9921-11-63.

19.

Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.

Uzum AK, Aydin MM, Tutuncu Y, Omer B, Kiyan E, Alagol F.

Eur J Intern Med. 2014 Apr;25(4):364-9. doi: 10.1016/j.ejim.2013.02.012. Epub 2013 Mar 21.

PMID:
23523152
20.

Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.

Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C.

Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1068-73.

PMID:
22013730

Supplemental Content

Support Center